+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygous mutations in the C6 gene of a child with recurrent infections



Compound heterozygous mutations in the C6 gene of a child with recurrent infections



Molecular Immunology 58(2): 201-205



The complement system plays an important role in both the innate and adaptive immune system. Patients with inherited complement deficiencies have an increased risk of systemic bacterial infections. Deficiencies of the terminal complement pathway are especially associated with invasive meningococcal disease. Here, we report a case of a boy that presented with arthritis and recurrent bacterial and viral infections. Extensive analyses revealed decreased complement activity of both classical and alternative pathway, indicating a deficiency of C3 or one of the factors of the terminal complement pathway. Mutational analysis of the C6 gene identified two compound heterozygous mutations. An unknown missense aberration was found that involves the loss of a cysteine, possibly affecting the 3D structure of the protein. Furthermore, a known splice site variation was identified that results in a 14% shorter protein, due to transcription of amino acids that are normally intronic until a stop codon is reached (exon-intron boundary defect). It is known that the protein with this latter aberration is still functionally active when present with other C6 mutations and therefore, the consequences of the combination of the identified variations have been studied. Quantitative ELISAs showed that at least one allele produced a circulating C6 molecule that can be incorporated in the membrane attack complex, likely the truncated protein. In the present case we observed relapsing bacterial and viral infections, but no meningococcal disease. The reduced complement activity can be explained by the identified genetic variations in C6, as recombinant C6 supplementation corrected complement function in vitro.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269141

Download citation: RISBibTeXText

PMID: 24378253

DOI: 10.1016/j.molimm.2013.11.023


Related references

A novel and a previously described compound heterozygous PKLR gene mutations causing pyruvate kinase deficiency in a Chinese child. Fetal and Pediatric Pathology 33(3): 182-190, 2014

Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. Journal of Clinical Endocrinology and Metabolism 92(6): 2223-2231, 2007

Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis. Lipids in Health and Disease 17(1): 144, 2018

Recurrent herpes simplex virus infection in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy associated with L29P and IVS9-1G>C compound heterozygous autoimmune regulator gene mutations. Journal of Internal Medicine 261(6): 605-610, 2007

Compound heterozygous mutations of ABCB11 responsible for benign recurrent intrahepatic cholestasis. Journal of Digestive Diseases 16(5): 299-302, 2016

Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Mutations in brief no. 159. Online. Human Mutation 12(2): 135, 2000

Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency. Human Molecular Genetics 5(12): 1925-1930, 1996

Whole-exome sequencing identifies compound heterozygous mutations in WDR62 in siblings with recurrent polymicrogyria. American Journal of Medical Genetics. Part a 155a(9): 2071-2077, 2012

Compound heterozygous mutations in MASP1 in a deaf child with absent cochlear nerves. Neurology. Genetics 3(3): E153, 2017

3-Hydroxyisobutyryl-CoA hydrolase deficiency in an Iranian child with novel HIBCH compound heterozygous mutations. Clinical Case Reports 7(2): 375-380, 2019

Novel compound heterozygous mutations in a child with Ataxia-Telangiectasia showing unrelated cerebellar disorders. Journal of the Neurological Sciences 371: 48-53, 2017

Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Laboratory Investigation; a Journal of Technical Methods and Pathology 78(2): 195-204, 1998

Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107(1): 349-354, 2005

New compound heterozygous mutations of p. Thr101Ilefs 2 and p. Thr306Ale in a child from a Chinese family with 17α-hydroxylase/17, 20-lyase deficiency. Genetics and Molecular Research 14(3): 9318-9324, 2016

Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: functional characterization and a review of the literature. Experimental Hematology 37(4): 495-503, 2009